SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

Molecular Cancer Therapeutics
Sean BuchananSiegfried H Reich

Abstract

The MET receptor tyrosine kinase has emerged as an important target for the development of novel cancer therapeutics. Activation of MET by mutation or gene amplification has been linked to kidney, gastric, and lung cancers. In other cancers, such as glioblastoma, autocrine activation of MET has been demonstrated. Several classes of ATP-competitive inhibitor have been described, which inhibit MET but also other kinases. Here, we describe SGX523, a novel, ATP-competitive kinase inhibitor remarkable for its exquisite selectivity for MET. SGX523 potently inhibited MET with an IC50 of 4 nmol/L and is >1,000-fold selective versus the >200-fold selectivity of other protein kinases tested in biochemical assays. Crystallographic study revealed that SGX523 stabilizes MET in a unique inactive conformation that is inaccessible to other protein kinases, suggesting an explanation for the selectivity. SGX523 inhibited MET-mediated signaling, cell proliferation, and cell migration at nanomolar concentrations but had no effect on signaling dependent on other protein kinases, including the closely related RON, even at micromolar concentrations. SGX523 inhibition of MET in vivo was associated with the dose-dependent inhibition of growth of tumor ...Continue Reading

References

Jun 20, 1986·Cell·M ParkG F Vande Woude
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·M JeffersG F Vande Woude
Jun 21, 2001·Proceedings of the National Academy of Sciences of the United States of America·B CaoG F Vande Woude
Dec 1, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Roger AbounaderJohn Laterra
Dec 10, 2002·Science·G ManningS Sudarsanam
Jul 30, 2003·Cancer Metastasis Reviews·Patrick C MaRavi Salgia
Oct 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nikolaus SchieringCinzia Cristiani
Dec 20, 2003·Nature Reviews. Molecular Cell Biology·Carmen BirchmeierGeorge F Vande Woude
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Mar 25, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick C MaRavi Salgia
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Gromoslaw A SmolenDaniel A Haber
Jun 20, 2006·Nature Chemical Biology·Yi Liu, Nathanael S Gray
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tobias MartensKatrin Lamszus
Sep 14, 2007·The Biochemical Journal·Jenny BainPhilip Cohen
Jan 5, 2008·Cancer Metastasis Reviews·Alessandra GentilePaolo M Comoglio
Jan 10, 2008·Nature Biotechnology·Mazen W KaramanPatrick P Zarrinkar
Apr 23, 2008·Journal of Medicinal Chemistry·Brian K AlbrechtSteven F Bellon
May 31, 2008·Nature Reviews. Drug Discovery·Paolo M ComoglioLivio Trusolino
Jun 14, 2008·Molecular Biology and Evolution·Salvatore D'AnielloJordi Garcia-Fernàndez

❮ Previous
Next ❯

Citations

May 2, 2012·Investigational New Drugs·Jeffrey R InfanteRamesh K Ramanathan
Jun 18, 2009·Journal of Computer-aided Molecular Design·Richard LawMark Whittaker
May 14, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·I CañadasE Arriola
May 4, 2012·Archives of Pharmacal Research·Kyung Hee JungSoon-Sun Hong
May 25, 2013·European Journal of Medicinal Chemistry·Lianbao YeShuguang Wu
Dec 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Qian XieGeorge F Vande Woude
Jan 21, 2011·The Journal of Biological Chemistry·Keith W RickertKevin J Lumb
Feb 22, 2012·Molecular & Cellular Proteomics : MCP·Jun ZhongAkhilesh Pandey
Jul 26, 2011·Journal of Translational Medicine·Joanna D HolbrookRakesh Kumar
Jun 5, 2013·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Vladimira KoudelakovaMarian Hajduch
Jun 7, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·O F OlmezO Manavoglu
May 6, 2014·European Journal of Medicinal Chemistry·Wei ZhangYingxia Li
Nov 10, 2013·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Yuri YamaguchiShin-Ichi Hayashi
Jul 12, 2011·Expert Opinion on Investigational Drugs·Xiangdong LiuPeggy A Scherle
Sep 28, 2010·Expert Opinion on Investigational Drugs·Giulia M StellaPaolo M Comoglio
May 7, 2015·Pharmacology & Therapeutics·Constantinos Alifieris, Dimitrios T Trafalis
Oct 25, 2011·International Journal of Cancer. Journal International Du Cancer·Chandrani ChattopadhyayElizabeth A Grimm
Jul 8, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Aya TanakaShinya Kimura
Feb 9, 2010·Cell Adhesion & Migration·Ryan E Lawrence, Ravi Salgia
Oct 28, 2016·The Journal of Pathology. Clinical Research·Fangjin HuangBeatrice S Knudsen
Jul 15, 2016·Journal of Medicinal Chemistry·Timothy P Heffron
Dec 23, 2008·Cancer Letters·Christine M Stellrecht, Varsha Gandhi
Apr 4, 2017·Expert Opinion on Therapeutic Patents·Daniel PlanoArun K Sharma
Mar 8, 2016·Neuropathology and Applied Neurobiology·Baogang ZhangShijun Lu
Sep 26, 2015·Cancers·Tarik Regad
Jan 26, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Meenakshi SinghBarak Akabayov
May 9, 2012·Nature Reviews. Clinical Oncology·Solange Peters, Alex A Adjei
Jan 25, 2012·Nature Reviews. Cancer·Ermanno GherardiGeorge Vande Woude
Jan 19, 2012·British Journal of Pharmacology·Joost C M UitdehaagGuido J R Zaman
Apr 17, 2012·Expert Review of Anticancer Therapy·Astrid BelalcazarEdgardo S Santos
Apr 28, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sharon DiamondSwamy Yeleswaram
Oct 22, 2013·International Journal of Molecular Medicine·Lisong Teng, Jun Lu
Jan 7, 2017·BMC Bioinformatics·Nicolas BoscPascal Bonnet
Sep 8, 2017·Molecular Biology of the Cell·Fabian E OrtegaJulie A Theriot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.